Acorah Software Products - Accounts Production 19.4.300 false true false true No description of principal activity 28 January 2025 31 January 2026 31 January 2026 16213536 Dr Joanna Naxton Dr Claire O'Malley iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16213536 2025-01-27 16213536 2026-01-31 16213536 2025-01-28 2026-01-31 16213536 frs-core:CurrentFinancialInstruments 2026-01-31 16213536 frs-bus:PrivateLimitedCompanyLtd 2025-01-28 2026-01-31 16213536 frs-bus:FilletedAccounts 2025-01-28 2026-01-31 16213536 frs-bus:Micro-entities 2025-01-28 2026-01-31 16213536 frs-bus:AuditExempt-NoAccountantsReport 2025-01-28 2026-01-31 16213536 frs-bus:Director1 2025-01-28 2026-01-31 16213536 frs-bus:Director2 2025-01-28 2026-01-31
Registered number: 16213536
Cj Therapeutic Productions Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2026
Balance Sheet
Registered number: 16213536
2026
£
Current assets 708
Creditors: Amounts Falling Due Within One Year (106 )
NET CURRENT ASSETS 602
TOTAL ASSETS LESS CURRENT LIABILITIES 602
Accruals and deferred income (299 )
NET ASSETS 303
CAPITAL AND RESERVES 303

Notes

1. General Information
Cj Therapeutic Productions Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16213536 . The registered office is 2 Marwood Terrace, Cotherstone, Barnard Castle, DL12 9PU.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2
2
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Joanna Naxton
Director
21st October 2026